Institutes outside Greece
APPLICATION OF DRUG DESIGN METHODS FOR INDUCING NERVE GROWTH FACTOR BIOSYNTHESIS
Abstract
dc:descriptionTHE CLINICAL POTENTIAL OF NERVE GROWTH FACTOR (NGF) AS A THERAPEUTIC AGENT FOR ALZHEIMER'S DISEASE IS UNDERMINED BY ITS INABILITY TO CROSS THE BLOOD BRAIN BARRIER. THE ALTERNATIVE OF UP-REGULATING NGF IN THE CENTRAL NERVOUS SYSTEM (CNS) BY NGF-INDUCING COMPOUNDS SEEMS MORE PROMISING, AND DELIVERY OF SUCH AGENTS TO THE BRAIN IS THEREFORE OF GREAT INTEREST. AN INTEGRATED APPROACH, USING DRUG DESIGN METHODS (SITE-SPECIFIC DELIVERY, ISOSTERIC SUBSTITUTION, AND STUDYOF QUANTITATIVE STRUCTURE ACTIVITY RELATIONSHIPS), WAS UNDERTAKEN TO 1) EFFECTIVELY STIMULATE NGF BIOSYNTHESIS IN THE CNS BY PERIPHERAL ADMINISTRATION OF ABRAIN-TARGETED CHEMICAL DELIVERY SYSTEM (CDS) OF A KNOWN INDUCER, 4-METHYLCATECHOL (4MC), 2) PRODUCE NOVEL NGF-INDUCING COMPOUNDS, AND 3) ELUCIDATE THE MECHANISM OF ACTION OF CATECHOL DERIVATIVES AS NGF-INDUCERS. BRAIN-TARGETED CDSS FOR 4MC BASED ON THE DIHYDROPYRIDINE <--> PYRIDINIUM REDOX REACTION WERE DESIGNED AND SYNTHESISED, AS WELL AS A NOVEL BRAIN-TARGETED CATECHOL DERIVATIVE. INVITRO STABILITY STUDIES AND IN VIVO DISTRIBUTION STUDIES IN RATS SUCCESSFULLY DEMONSTRATED THE FEASIBILITY OF SUSTAINED DELIVERY OF 4MC AND DERIVATIVE TO THE RAT BRAIN AFTER PERIPHERAL ADMINISTRATION OF THE CORRESPONDING DIHYDROPYRIDINE CHEMICAL DELIVERY SYSTEMS, AND RAPID PERIPHERAL ELIMINATION TO ASSURE MINIMAL PERIPHERAL SIDE EFFECTS OF THE BIOACTIVE COMPOUNDS. MOREOVER, THE 4MC-CDS EVOKED A 1.8-FOLD INCREASE IN NGF MRNA IN THE HIPPOCAMPAL REGION OF THE RAT BRAIN. BIOISOSTERS OF 4MC WERE SYNTHESISED AND EVALUATED FOR IN VITRO NGF-INDUCING ACTIVITY IN TWO CELL LINES. (ABSTRACT TRUNCATED)
Degree
thesis:*- Grantor dc:publisher
- Institutes outside Greece
- Year dc:date
- 1995
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Kourounakis, Angeliki
- Κουρουνάκη, Αγγελική
Subjects
dc:subject × 4Rights
- Language dc:language
- eng
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/5220